Wikidata entity: Q241006
C₄₆H₆₄N₁₄O₁₂S₂ (P274)
Quantities
| P4250 | defined daily dose | 0.4 |
| P2067 | mass | 1068.426956 |
| P3780 | active ingredient in | ... | Q128697506 (Minirin) | Minirin |
| P3780 | active ingredient in | ... | Q128697834 (Nocdurna) | Nocdurna |
| P3780 | active ingredient in | ... | Q128781939 (Octostim) | Octostim |
| P3780 | active ingredient in | ... | Q128782196 (Adiuretin) | Adiuretin |
| P3780 | active ingredient in | ... | Q128782616 (Uropres) | Uropres |
| P3780 | active ingredient in | ... | Q128799450 (Nocutil) | Nocutil |
| P3780 | active ingredient in | ... | Q47521441 (DDAVP) | DDAVP |
| P3780 | active ingredient in | ... | Q47521904 (Noctiva) | Noctiva |
| P3780 | active ingredient in | ... | Q47522152 (Stimate) | Stimate |
| P3772 | agonist of | ... | Q4789588 (Arginine vasopressin receptor 2) | Arginine vasopressin receptor 2 |
| P3772 | agonist of | ... | Q21124841 (arginine vasopressin) | arginine vasopressin |
| P233 | canonical SMILES | String | C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N | ??? |
| P373 | Commons category | String | Desmopressin | ??? |
| P366 | has use | ... | Q12140 (medication) | medication |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P2017 | isomeric SMILES | String | C1C[C@H](N(C1)C(=O)[C@@H]2CSSCCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(=O)N | ??? |
| P2175 | medical condition treated | ... | Q166019 (bleeding) | bleeding |
| P2175 | medical condition treated | ... | Q220551 (diabetes insipidus) | diabetes insipidus |
| P2175 | medical condition treated | ... | Q709360 (von Willebrand's disease) | von Willebrand's disease |
| P2175 | medical condition treated | ... | Q1426443 (nocturia) | nocturia |
| P2175 | medical condition treated | ... | Q1641429 (hyposthenuria) | hyposthenuria |
| P2175 | medical condition treated | ... | Q3448862 (enuresis) | enuresis |
| P2175 | medical condition treated | ... | Q585285 (thrombocytopenia) | thrombocytopenia |
| P2175 | medical condition treated | ... | Q611571 (hemorrhagic disease) | hemorrhagic disease |
| P2175 | medical condition treated | ... | Q12412172 (central diabetes insipidus) | central diabetes insipidus |
| P2175 | medical condition treated | ... | Q55790286 (gestational diabetes insipidus) | gestational diabetes insipidus |
| P1748 | NCI Thesaurus ID | String | C61701 | ??? |
| P129 | physically interacts with | ... | Q4789584 (Arginine vasopressin receptor 1A) | Arginine vasopressin receptor 1A |
| P129 | physically interacts with | ... | Q4789587 (Arginine vasopressin receptor 1B) | Arginine vasopressin receptor 1B |
| P129 | physically interacts with | ... | Q4789588 (Arginine vasopressin receptor 2) | Arginine vasopressin receptor 2 |
| P3489 | pregnancy category | ... | Q3679233 (Australian pregnancy category B2) | Australian pregnancy category B2 |
| P3489 | pregnancy category | ... | Q28123616 (US pregnancy category B) | US pregnancy category B |
| P769 | significant drug interaction | ... | Q275926 (bumetanide) | bumetanide |
| P769 | significant drug interaction | ... | Q388801 (furosemide) | furosemide |
| P769 | significant drug interaction | ... | Q407617 (sertraline) | sertraline |
| P769 | significant drug interaction | ... | Q408471 (paroxetine) | paroxetine |
| P769 | significant drug interaction | ... | Q409236 (fluvoxamine) | fluvoxamine |
| P769 | significant drug interaction | ... | Q409672 ((RS)-citalopram) | (RS)-citalopram |
| P769 | significant drug interaction | ... | Q410412 (carbamazepin) | carbamazepin |
| P769 | significant drug interaction | ... | Q422244 (fluoxetine) | fluoxetine |
| P769 | significant drug interaction | ... | Q423930 (hydrochlorothiazide) | hydrochlorothiazide |
| P769 | significant drug interaction | ... | Q1078392 (indapamide) | indapamide |
| P769 | significant drug interaction | ... | Q1169164 ((RS)-bendroflumethiazide) | (RS)-bendroflumethiazide |
| P769 | significant drug interaction | ... | Q425289 (chlorthalidone) | chlorthalidone |
| P769 | significant drug interaction | ... | Q5135114 ((2RS,6RS)-clopamide) | (2RS,6RS)-clopamide |
| P279 | subclass of | ... | Q126615642 (Ddavp) | Ddavp |
| P2868 | subject has role | ... | Q35456 (essential medicine) | essential medicine |
| P2868 | subject has role | ... | Q1642182 (antihemorrhagic) | antihemorrhagic |
| P2868 | subject has role | ... | Q4774696 (antidiuretic) | antidiuretic |
| P2868 | subject has role | ... | Q7916882 (Vasopressin receptor agonist) | Vasopressin receptor agonist |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | desmopressin | ??? |
Why not click here or view trends?
log id: 1880117